CTRI/2017/08/009517已完成2 期
Efficacy and safety of addition of short course of prednisolone to gluten free diet (GFD) versus gluten free diet alone in the clinical, immunological and histological recovery of celiac disease.
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •New cases of Celiac Disease
- •-Both sexes
- •-Age: 1-18 years
排除标准
- •1. Partially treated celiac disease
- •2. Coexistent systemic disease
- •3. HIV seropositive or HBs Ag positive
- •4. Past H/O tuberculosis or evidence of active tuberculosis
- •5. Unwillling patients / parents
研究者
相似试验
招募中
4 期
The investigation of safety and efficacy of short hydration GC therapy in metastatic urothelial carcinoma patientsadvanced or metastatic urothelial carcinoma patientsJPRN-UMIN000032901agoya City University Graduate School of Medical Sciences10
尚未招募
不适用
Safety and Effectiveness of Short Course Anrtimicrobial Therapy for Acute Cholangitis: Open-label Randomized Controlled TrialJPRN-UMIN000028382Kobe University182
已完成
不适用
Investigation of short-term efficacy and safety of 5-alpha reductase inhibitor in the patients with BPHJPRN-UMIN000025443ara Medical University200
尚未招募
3 期
Evaluation of the Safety and Efficacy of Short-term A 002 Treatment in Subjects with Acute Coronary SyndromesHeart AttackHeart Disease10082206NL-OMON34504Anthera Pharmaceuticals, Inc576
进行中（未招募）
不适用
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes - VISTA-16Treatment of patients with Acute Coronary Syndromes (ACS)MedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2009-016812-18-CZAnthera Pharmaceuticals, Inc.6,504